Tissue Banking Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Tissue Banking Market covers analysis By Product (Equipment, Consumables, Media, and Accessories), By Application (Drug Discovery, Therapeutic, and Medical research), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPMD00002345
  • Category : Medical Device
  • No. of Pages : 152

Tissue Banking Market Opportunities 2031

Buy Now

MARKET OVERVIEW

A tissue bank is an licensed, accredited, or regulated under federal organization that provides donor screening, recovery, processing, storage, and/or distribution of allograft tissue. A tissue bank may also refer to a location where biomedical tissue is stored under cryogenic conditions and is generally used in a more clinical sense. Some of the tissues which are stored in these banks includes bone, corneas and retinas, dura mater, vascular and cardiac tissue, reproductive tissue, skin and cellular tissues.

MARKET SCOPE

The "Tissue Banking Market Analysis to 2031" is a specialized and in-depth examination of the healthcare industry, with a particular emphasis on regional market trend analysis. The purpose of this report is to provide an overview of the tissue banking market, as well as detailed market segmentation based on products, tissue type, and application. Additionally, the report offers key statistics on the market status of the leading tissue banking market players, as well as key market trends and opportunities.

MARKET SEGMENTATION

  • Based on products, the market is segmented into equipment, consumables, media, and accessories.
  • Based on tissue type, the market is segmented into heart valves, cornea, brain and spinal cord, and others.
  • Based on application, the market is segmented into drug discovery, therapeutic, and medical research.

MARKET DYNAMICS

Drivers-

  • Increasing number of bio banks across the globe
  • Advances in regenerative medicine and advances in the treatment of cell and tissue disorders

Restraint-

  • High transplant expense and lack of tissue banks in many remote countries

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2022 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The tissue banking market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, Asia Pacific, Middle East & Africa, and South America after evaluating political, economic, social, and technological factors affecting the tissue banking market in these regions.

Impact of COVID-19 on Tissue Banking Market

The limited availability of resources, including trained staff and medical equipment; and the burden of noncommunicable diseases harm the overall healthcare system. In 2021, the COVID-19 pandemic had a significant impact on the delivery and accessibility of social services, education, health and nutrition, healthcare spending, and wellbeing- and development-related businesses. The COVID-19 pandemic moderately propelled the growth of the tissue banking market. According to a report in November 2021 by Organization for Economic Co-operation and Development (OECD), prevention and treatment services for oral disease, cancer, and diabetes have been severely disrupted since the pandemic began. Thus, there has been a negative impact on the tissue banking market during the first quarter of the COVID-19 period due to the lockdown and limited access to healthcare-related settings. However, post-COVID, there has been a high demand for replacement tissues owing to the surge in surgical procedures and replacement of tissues due to diseases, trauma, or congenital issues that contributes to the tissue banking market’s future growth.

Tissue Banking Market Report Analysis

Tissue Banking Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Thermo Fisher Scientific Inc
  • AL CHI MI A srl
  • VWR Corporation
  • BioLife Solutions Inc
  • PHC Corporation
  • BioKryo GmbH
  • Merck KGaA
  • Bluechiip Limited
  • Hamilton Company

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Product
  • Equipment
  • Consumables
  • Media
  • Accessories
Market Segment By Application
  • Drug Discovery
  • Therapeutic
  • Medical research
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

The report covers key developments in the tissue banking market with focus on two  main strategies such as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies that includes new product launches, product approvals by the authorized bodies, and others such as patents and events. Inorganic growth strategies activities normally  includes strategic acquisitions, and partnership & collaborations between the companies. These activities have paved way for the expansion of business and customer base of market players. The market payers from tissue banking market are anticipated to lucrative growth opportunities in the future with the rising demand for tissue banking globally.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the tissue banking market. Also, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.

  • Thermo Fisher Scientific Inc.
  • AL.CHI.MI.A. srl
  • VWR Corporation
  • BioLife Solutions Inc.
  • PHC Corporation
  • BioKryo GmbH
  • Merck KGaA
  • Bluechiip Limited
  • Hamilton Company
  • QIAGEN

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Tissue Banking Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Equipment
  • Consumables
  • Media
  • Accessories
By Application
  • Drug Discovery
  • Therapeutic
  • Medical research
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • AL CHI MI A srl
  • VWR Corporation
  • BioLife Solutions Inc
  • PHC Corporation
  • BioKryo GmbH
  • Merck KGaA
  • Bluechiip Limited
  • Hamilton Company
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

  • Thermo Fisher Scientific Inc.
  • AL.CHI.MI.A. srl
  • VWR Corporation
  • BioLife Solutions Inc.
  • PHC Corporation
  • BioKryo GmbH
  • Merck KGaA
  • Bluechiip Limited
  • Hamilton Company
  • QIAGEN

Trends and growth analysis reports related to Medical Device : READ MORE..